SEATTLE--(BUSINESS WIRE)--Tasso, Inc., the leading provider of patient-centric, clinical grade blood collection solutions, today announced the launch of its next generation technology for dried blood ...

Tasso, maker of at-home blood sample collection systems, is launching the next generation of its devices that aim to support patients enrolled in clinical trials and simplify their participation in ...

Jan 19 (Reuters) - The U.S. health regulator said on Wednesday it was expanding the medical device shortage list to include all blood specimen collection tubes due to supply challenges led by an ...

Shortly after securing an FDA clearance last month for its simple, self-operated blood sample collection device, Tasso has teamed up with Catapult Health to help propel its device into people’s homes.

The concentration quantification of an analyte (e.g., glucose, cholesterol, antigens, enzymes) in a physiological sample (e.g., saliva, urine, blood) plays a prominent role in the diagnosis and ...

Tasso and InnoVero developed a less-invasive anti-doping blood test being used broadly at the Olympics for the first time.

With the rise of telemedicine, accelerated by the COVID-19 pandemic, the need for the general public to be able to safely and successfully collect samples for testing has been highlighted. To meet ...